Speaker Lecture Titles


​Surname

First Name​

​Country 

​Abstract Title

​Albanese​Emiliano​Switzerland​SEX AND/OR GENDER EFFECT ON DEMENTIA AND AD INCIDENCE, A CRITICAL APPRAISAL OF THE EPIDEMIOLOGICAL EVIDENCE
​Bateman​Randall​USATHE DOMINANTLY INHERITED ALZHEIMER NETWORK TRIALS, COORDINATION AND IMPLICATIONS FOR SPORADIC ALZHEIMER'S DISEASE PREVENTION TRIALS
​Bernabei​Roberto​Italy

THE PUZZLE OF TREATING ALZHEIMER’S IN TRADITIONAL SETTINGS

​BourasConstantin​Switzerland​

CENTENARIAN BRAINS, ARE THEY DIFFERENT?

​Blennow​Kaj​Sweden​UPDATE ON NOVEL CSF AND BLOOD BIOMARKERS FOR ALZHEIMER’S DISEASE - IMPLEMENTATION IN CLINICAL TRIALS
​Buée​Luc​FranceNEURON TO NEURON TAU TRANSFER: WHICH CONSEQUENCES FOR TAU IMMUNOTHERAPY?
​Cattaneo​AnnaMaria​ItalyROLE OF THE GUT MICROBIOTA IN ALZHEIMER DISEASE: EVIDENCES FROM PRECLINICAL AND CLINICAL STUDIES
​Checler​Frédéric​FranceBETACTF-AUTOPHAGY INTERPLAY AND ITS DYSFUNCTION IN ALZHEIMER’S DISEASE​
​Cuello​A. Claudio​Canada​RITA, NGF AND ALZHEIMER’S DISEASE
​Dimanico​Ugo​Italy​FALLS IN OLDER PEOPLE: EPIDEMIOLOGY, RISK FACTORS, INSTRUMENTAL ASSESSMENT AND REHABILITATION FOR PREVENTION
​Di Luca​Monica​Italy

ADAM10 AS A POTENTIAL TARGET FOR INNOVATIVE THERAPEUTIC APPROACHES IN ALZHEIMER DISEASE

​Ferretti​Maria​Switzerland​DOES ALZHEIMER'S DISEASE AFFECT MEN AND WOMEN EQUALLY? HOW SEX-SPECIFIC DISEASE PRESENTATION MIGHT CONTRIBUTE TO PHENOTYPIC VARIABILITY IN ALZHEIMER'S 
​Fox​Nick​UK
IMAGING OF FAMILIAL ALZHEIMER’S DISEASE: SEEING WHAT ALZHEIMER COULD NOT SEE
​Fratiglioni​Laura​Sweden​ENHANCING COGNITIVE RESERVE OVER THE LIFESPAN CONTRIBUTE TO HEALTHY BRAIN AGING
​Frisoni​Giovanni​Switzerland​A ROADMAP FOR THE VALIDATION OF AD BIOMARKERS TO ACCELERATE THEIR USE IN THE CLINIC
​Geula​Changiz​USA

NEUROBIOLOGIC CORRELATES OF COGNITIVE SUPERAGING

​Giacobini​Ezio​Switzerland​TWENTY FIVE YEARS OF CHOLINERGIC THERAPY IN AD : WHAT HAVE WE LEARNED?
​Giladi​NirIsrael​​MULTI DIMENSIONAL REHABILITATION IN PARKINSON'S DISEASE
​Gold​GabrielSwitzerland​​TBC
​Growdon​JohnUSA​​ANTI-ABETA AND ANTI-TAU TREATMENTS WILL BENEFIT PARKINSON DISEASE
​Hampel​HaraldFrance
​NEUROIMAGING OF THE BASAL FOREBRAIN CHOLINERGIC SYSTEM AND THE EFFECT OF DONEPEZIL ON BRAIN ATROPHY 
​Herrmann​Francois​Switzerland​COMPARISON OF CENTENARIANS’ COGNITION ACROSS  5 COUNTRIES, RESULTS FROM THE 5-COOP STUDY
​Heneka​Michael​Germany​MICROGLIA RESPONSE DURING THE COURSE OF ALZHEIMER DISEASE : A TARGET FOR THERAPY?
​Iqbal​Khalid​USA​PREVENTION OF TAU AND ABETA PATHOLOGIES BY RESCUING NEURONAL CONNECTIVITY DEFICIT
​Jagust​William​USA​IMAGING RELATIONSHIPS BETWEEN BETA-AMYLOID, TAU AND COGNITION
​Kawas​Claudia​USA​IMPACT OF INTERVENTIONS TO REDUCE DEMENTIA IN THE OLDEST-OLD
​Kantarci​Kejal​USADEMENTIA WITH LEWY BODIES: IMAGING BIOMARKERS
​Kivipelto​Miia​Sweden​FROM FINGER TO WORLD WIDE FINGERS: GLOBAL MULTI-DOMAIN INTERVENTION TRIALS  
​LangbaumJessica​USA​THE ALZHEIMER’S PREVENTION INITIATIVE: EVALUATING PROMISING THERAPIES IN AT-RISK POPULATIONS
​Lee​Virginia​USA
ALPHA-SYNUCLEIN STRAINS AND TRANSMISSION
​Longo​Frank​USA​TARGETING OF THE P75 NEUROTROPHIN RECEPTOR INHIBITS AΒ AND TAU OLIGOMER TOXICITY: DESIGN OF CURRENT PHASE 2A STUDY IN ALZHEIMER’S DISEASE
​Mandelkow​Eva-Maria​GermanyTOXICITY, HYPOMETABOLISM, AND RESCUE IN TRANSGENIC MICE EXPRESSING PRO-AGGREGANT TAU
​Marek​Ken​USA​TBC
​McKeith​Ian​USA​DIAGNOSIS AND TREATMENT OF DLB
​Mecocci​Patrizia​Italy​SHORT- AND  LONG-TERM RESPONSE TO ACHEIS IN  ALZHEIMER'S DISEASE: THE OLDER THE BETTER
​Michaelson​DannyIsrael​​DEVELOPMENT OF APOE4 TARGETED TREATMENT OF ALZHEIMER'S DISEASE
​Morris​JohnUSA​​DO LESSONS FROM DOMINANTLY INHERITED AD EXTRAPOLATE TO SPORADIC LATE ONSET AD
​Nobili​FlavioSwitzerland​MOLECULAR IMAGING IN PRODROMAL AND EARLY PD
​Nordberg​Agneta​Sweden​INFLAMMATION IN AD IN RELATION TO AMYLOID DEPOSITION, TAU SPREADING AND GLUCOSE HYPOMETABOLISM
​Nitsch​Roger​Switzerland​TBC
​Pane​KatiaItaly​GUT MICROBIOTA: IMPLICATIONS IN NEURODEGENERATIVE DISEASES 
​Rocca​Walter​USA
​TIME TRENDS IN THE INCIDENCE OF DEMENTIA AND PARKINSONISM
​Schmitz​Taylor​USA​TRIANGULATING CELL-TYPE SPECIFIC DEGENERATION OF THE CHOLINERGIC BASAL FOREBRAIN IN PRECLINICAL ALZHEIMER’S DISEASE
​Sisodia​SamUSA​INFLUENCE OF THE MICROBIOME ON AB DEPOSITION AND NEUROINFLAMMATION IN MOUSE MODELS
​Stocchi​Fabrizio​ItalyFUTURE DIRECTIONS IN THE TREATMENT OF PARKINSON’S DISEASE
​Tamagno​Elena​Italy​MECHANISMS OF PROTEIN TAU AGGREGATION
​Trabucchi​Marco​ItalyALZHEIMER PATIENTS AND SOMATIC DISEASES: HOSPITAL VS HOME TREATMENT
​Trojanowski​John​USA​NEW MODELS OF TAUOPATHIES AND INTERACTIONS OF PLAQUES WITH TANGLES IN AD MOUSE MODELS
​Vassar​Robert​USA​THE PROMISE AND CHALLENGE OF BACE1 INHIBITION FOR ALZHEIMER’S DISEASE
​Villemagne​Victor​Australia​THE TIMES AND TRIBULATIONS OF TAU IMAGING
​Weiner​Michael​USA​ACCELERATING CLINICAL TRIALS WITH BIOMARKERS AND TECHNOLOGY: ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE AND BRAIN HEALTH REGISTRY

Keep Me Updated